Hyperthermic intraperitoneal chemotherapy for gastric and colorectal cancer in Mainland China

Table 1 Hospitals performing HIPEC in different areas of Mainland China

Areas in mainland China	Hospitals	No. of trials	No. of trials (No. of patients)			No. of trials for different types of HIPEC			No. of trials that were performed for reasons other than HIPEC
			GC	CRC	GC andCRC	iHIPEC	pHIPEC	iHIPEC, pHIPEC	Prophylactic	Palliative	Curative
Beijing	1	1	1 (169)			1			1
Shanghai1	4	4	3 (30, 52, 104)		1 (25)	2		2	4	1
Tianjin	2	2	1 (41)		1 (32)		2		2
Chongqing	1	1	1 (54)				1		1
Guangdong1	9	13	5 (63, 61, 25, 32, 44)	5 (44, 35, 20, 53, 358)	3 (30, 72, 157)	5	6	2	12	2
Guangxi1	4	4	3 (29, 30, 35)	1 (68)		4			4	1
Anhui1	5	5	3 (278, 25, 42)	1 (32)	1 (80)	1	4		5	1
Zhejiang	9	10	8 (58, 135, 43, 40, 31, 32, 146, 45)		2 (76, 81)	4	6		10
Jiangsu	8	10	8 (31, 38, 45, 46, 100, 25, 29, 32)		2 (58, 49)	3	7		10
Henan1	11	13	9 (35, 34, 43, 50, 234, 49, 29, 32, 30)	2 (52, 87)	2 (48, 29)	5	7	1	11	3
Hebei1	2	4	3 (30, 68, 37)	1 (68)		3	1		4	1
Shandong1	5	7	5 (34, 45, 72, 53, 32)		2 (21, 63)	2	5		5	4
Fujian	2	2	2 (68, 304)				2		2
Hubei	4	4	2 (23, 56)		2 (68, 17)	2	1	1	3		1
Hunan	1	1	1 (35)				1		1
Liaoning1	4	5	3 (128, 198, 17)	2 (35, 138)		3	2		4	2
Jilin	1	2	1 (35)	1 (18)			2		1	1
Shaanxi	2	2	1 (160)	1 (40)		1	1		2
Ningxia	1	1	1 (82)			1			1
Gansu1	2	2	2 (25, 50)				1	1	2	1
Neimeng	2	2	1 (36)		1 (24)	1	1		2
Sichuan	2	2	2 (33, 71)			1	1		2
Jiangxi	2	2	1 (96)		1 (30)	2			2
Yunnan	1	1			1 (25)			1	1
Xinjiang	1	1	1 (136)			1			1
Total1(trial number)	86	101	68	14	19	42	51	8	91	17	1

GC: Gastric cancer; CRC: Colorectal cancer; PC: Peritoneal carcinomatosis; HIPEC: Hyperthermic intraperitoneal chemotherapy; iHIPEC: Intraoperative HIPEC; pHIPEC: Postoperative HIPEC.

¹A trial including both prophylactic and palliative strategies was counted twice according different purposes of HIPEC.